Cenntro Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cenntro Electric Group Limited covers the month of September 2022, specifically dated September 16, 2022. The report discloses material changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Departure of Director: Justin Davis-Rice resigned as a member of the Board of Directors effective immediately on September 16, 2022. The resignation was not the result of any disagreement with the Company's operations, policies, or procedures.
- Appointment of Director: Dr. Yi Zeng was appointed as an independent director to fill the vacancy created by Mr. Davis-Rice's resignation, effective immediately. His term lasts until the next annual meeting of shareholders or until his successor is elected.
- Compensation: Dr. Zeng's annual compensation is set at US$45,000.
Outlook, Risks, and Management Commentary
The Board determined that Dr. Zeng qualifies as an "independent" director under Nasdaq Listing Rule 5605(a)(2). Dr. Zeng brings over 30 years of experience in the energy industry, management, marketing, and research, including prior roles at Range Resources Pty. Ltd., Kori Ltd., Lomon Pty. Ltd., and BHP Billiton. There are no reported family relationships between Dr. Zeng and other employees or Board members, and no reportable transactions occurred in the past two years.
Key Facts for Investor Verification
- Verify the effective date of Dr. Yi Zeng's appointment and the immediate departure of Justin Davis-Rice.
- Confirm Dr. Zeng's independence status under Nasdaq Listing Rule 5605(a)(2).
- Review the attached Director Offer Letter (Exhibit 10.1) for full terms of the US$45,000 annual compensation.
- Check for any subsequent filings regarding the Company's next annual meeting of shareholders to determine the duration of Dr. Zeng's interim term.